Emcure Pharma IPO Listing: Stock lists at 31% premium on NSE

Emcure Pharma’s IPO Roar: Decoding the Investor Frenzy and Unveiling the Company’s Future Emcure Pharma’s recent IPO wasn’t just a listing; it was a market roar. Led by...